Insight

EORTC meta-analysis: Progression-free survival as surrogate in advanced cervical carcinoma

EORTC/X

Jan 16, 2025, 08:49

EORTC meta-analysis: Progression-free survival as surrogate in advanced cervical carcinoma

European Organisation for Research and Treatment of Cancer shared a post on X about a recent paper by Ramon Yarza et al. published in the International Journal of Gynecological Cancer:

“A new EORTC meta-analysis of 20 studies highlights the potential of progression-free survival as a surrogate endpoint for overall survival in advanced cervical carcinoma, especially in chemoimmunotherapy trials.”

“Progression-free survival as a potential surrogate end point for overall survival in advanced cervical carcinoma”

Authors: Ramon Yarza, Melpomeni Kountouri, Helena Guedes, Catherine O’Gorman, Jose Manuel Estrada-Lorenzo, Corneel Coens, Judith Kroep, Fernanda Herrera, Ainhoa Madariaga.

More posts featuring EORTC.

Ainhoa Madariaga cancer Catherine O’Gorman cervical carcinoma Corneel Coens EORTC European Organisation for Research and Treatment of Cancer Fernanda Herrera Helena Guedes Jose Manuel Estrada-Lorenzo Judith Kroep Melpomeni Kountouri OncoDaily Oncology Ramon Yarza

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage